Biopsys Medical Inc.
Division of Johnson & Johnson
Latest From Biopsys Medical Inc.
Noted physician/entrepreneur Tom Fogarty has long been known for inventing breakthrough new products, but here he discusses his recent efforts focused on working to protect the medical device innovation model and correct what he sees as serious flaws that may hinder its long-term viability, especially in the US.
The dean of device physician-entrepreneurs is launching a new crop of start-ups. Here Thomas Fogarty, MD, a cardiovascular surgeon and the entrepreneur behind more than 30 device companies, talks about the current key issues in device company creation.
Embroiled in a dispute over intellectual property royalties, physician/inventor/entrepreneur Thomas Fogarty, MD, and Three Arch Partners, the venture firm he co-founded in 1993, have parted company.
For more than 40 years, Tom Fogarty has played a central role in global medical device innovation. Following a fruitful relationship with Edwards, which saw the development of the Fogarty embolectomy catheter and artficial heart valve, Fogarty went on to launch his own companies, including General Surgical, CTS, and Biopsys, to name just a few. In this interview, taken from a lecture series at Stanford University, Fogarty talks about his early days as a device innovator and how medical device innovation has changed today.